|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
16.09.25 - 17:30
|
Plasmid DNA Manufacturing Market Report 2025-2035, with Profiles of AGC Biologics, Aldevron, Biomay, Charles River, Cytovance Biologics, Forge Biologics, GenScript ProBio, VGXI, and More - ResearchAndMarkets.com (Business Wire)
|
|
|
DUBLIN--(BUSINESS WIRE)--The "Plasmid DNA Manufacturing Market Industry Trends and Global Forecasts to 2035, by Scale of Operation, Application Area, Therapeutic Area, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global plasmid DNA manufacturing market is estimated to grow from USD 0.1 billion in 2025 to USD 0.53 billion by 2035, at a CAGR of 14.85% during the forecast period, to 2035.
Plasmid DNA Manufacturing Market: Growth and Trends
Owing to the increasing research and development initiatives for advanced therapeutics medicinal products (ATMPs), the field of plasmid DNA manufacturing is experiencing extensive growth. Ongoing efforts for plasmid DNA aim to overcome existing challenges and further expand the applications of plasmid DNA in various fields, including cell and gene therapy development, nucleic acid vaccine development and viral vector manufacturing. However, due to various challenges associated with plasmid DNA manufacturing process, including the high cos...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09.06.25 - 06:15
|
Midday Takeaway: HSI Up 240 pts; HSTI Up 121 pts; MEITUAN Up over 5%; HKEX, CCB, NTES, OCUMENSION-B, GENSCRIPT BIO Hit New Highs (AAStocks)
|
|
|
At midday close, HSI rose 240 pts or 1.0% to 24,033. HSTI rose 121 pts or 2.3% to 5,408. HSCEI gained 95 pts or 1.1% to 8,724.Active Heavyweights:MEITUAN (03690.HK) closed at $149, up 5.2%HKEX (00388.HK) closed at $412.2, up 2.4%, hitting new highPING AN (02318.HK) closed at $46.75, up 2.3%BABA (09988.HK) closed at $118.8, up 1.......
|
|
|
08.04.25 - 15:42
|
GenScript Biotech Releases 2024 ESG Report, Highlighting Sustainability Practices and Progress (PR Newswire)
|
|
|
PISCATAWAY, N.J., April 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation (GenScript), a global leader in life sciences research, manufacturing technologies, and production services, has released its 2024 Environmental, Social, and Governance (ESG) report. The report highlights the......
|
|
|
|
|
|
|
|
|
13.03.25 - 03:15
|
Research: BOCI Drops GENSCRIPT BIO TP to $21, Keeps Rating at Buy (AAStocks)
|
|
|
GENSCRIPT BIO (01548.HK)'s 2024 revenue amounted to US$594 million, with a net profit of US$2.9 billion, mainly driven by a US$3.2 billion one-time gain from the spin-off of Legend Biotech (LEGN.US), BOCI released a research report saying. Moreover, the core business reported a net loss of US$174 million, reflecting continue......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
